- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.03. | FDA Commissioner pick Makary pressed by Senators on vaccines | ||
| 06.03. | Digital health firm XRHealth hits the M&A trial again | ||
| 06.03. | Trump's NIH pick closer to role as court blocks budget cuts | ||
| 06.03. | NICE agrees to look again at Alzheimer's drug Leqembi | ||
| 06.03. | Second senior NHS England executive heads for the exit | ||
| 06.03. | Novo Nordisk follows Lilly into DTC obesity drug market | ||
| 05.03. | Jazz swings further into cancer with Chimerix takeover | ||
| 05.03. | FDA starts review of Roche's Gazyva in lupus nephritis | ||
| 05.03. | Lawrence Tallon will lead MHRA after June Raine retires | ||
| 05.03. | Bayer CEO warns of tough 2025 as turnaround plan beds in | ||
| 05.03. | FDA approves first generics of anticoagulant Xarelto | ||
| 04.03. | Enhertu extends survival in advanced gastric cancer | ||
| 04.03. | Sofinnova raises €1.2bn to back 'up to 60' companies | ||
| 04.03. | Roche ends the 30-year US hiatus in new stroke drugs | ||
| 04.03. | Pharma urges NHS to put medicines at heart of 10-year plan | ||
| 04.03. | Lilly uses Oscars ad to warn about 'untested' GLP-1s | ||
| 03.03. | Takeda scores with polycythemia vera drug in phase 3 trial | ||
| 03.03. | Australia stands firm on 'no' to Alzheimer's drug Leqembi | ||
| 03.03. | GSK bows to Trump pressure and pauses diversity policies | ||
| 03.03. | UK haemophilia A patients get once-weekly treatment option | ||
| 03.03. | AbbVie pays Gubra $350m upfront to enter obesity field | ||
| 28.02. | Spain agrees to reimburse Orchard's gene therapy Libmeldy | ||
| 28.02. | AbbVie closes on Rinvoq approval in inflamed artery disease | ||
| 28.02. | FDA clears lifesaving feature for Google's Pixel Watch 3 | ||
| 28.02. | Owkin launches ATLANTIS patient data mining project |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
